Loading…
Lobbying Spend
—
Filings
6
Firms Hired
1
Active Period
2009–2010
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · second_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legality of internet prescriptions. Monitor S. 525, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes (Short Title: Pharmaceutical Market Access and Drug Safety Act of 2009).
Client expense: — · Firm income: $22,500
Matched citations: S. 525
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · first_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legality of internet prescriptions. Monitor S. 525, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes (Short Title: Pharmaceutical Market Access and Drug Safety Act of 2009).
Client expense: — · Firm income: $27,000
Matched citations: S. 525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · fourth_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legality of internet prescriptions. Monitor S. 525, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes (Short Title: Pharmaceutical Market Access and Drug Safety Act of 2009).
Client expense: — · Firm income: $36,000
Matched citations: S. 525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · third_quarter · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legality of internet prescriptions. Monitor S. 525, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes (Short Title: Pharmaceutical Market Access and Drug Safety Act of 2009).
Client expense: — · Firm income: $36,000
Matched citations: S. 525
Source: Senate LDA